Connected Home Medical Monitoring Devices to Reach 160 Million by 2030

The global installed base of connected home medical monitoring devices is expected to grow from 92.7 million in 2025 to nearly 160 million by 2030, according to Berg Insight. Diabetes management, cardiac monitoring and medication adherence are helping drive a broader shift towards continuous, data-driven healthcare outside hospitals.

Healthcare providers are increasingly extending patient monitoring beyond hospitals and clinics, using connected medical devices to track chronic conditions, assess treatment adherence and identify potential complications earlier. As remote care becomes more established, the challenge is shifting from simply collecting patient data to integrating that information into clinical workflows and supporting timely medical interventions.

New research from Berg Insight highlights the scale of this transition. The analyst firm estimates that 92.7 million connected home medical monitoring devices were in use worldwide at the end of 2025. That figure is projected to reach 159.7 million by 2030, representing a compound annual growth rate (CAGR) of 11.5%.

Importantly, these figures cover connected medical devices used by patients enrolled in structured healthcare programmes. Consumer fitness trackers and personal wellness devices used outside prescribed care regimens are excluded, making the forecast a more focused indicator of clinical IoT adoption rather than the broader wearable technology market.

Sleep Therapy Dominates, While Diabetes Monitoring Gains Momentum

Three application areas account for much of the connected home medical monitoring market: sleep therapy, diabetes management and implantable cardiac rhythm management (CRM).

Sleep therapy remains the largest segment, with ResMed holding a dominant position alongside manufacturers including Philips, BMC Medical and Löwenstein Medical Technology. The number of remotely monitored sleep therapy patients has more than doubled since 2018, largely supported by treatment compliance monitoring requirements introduced in the US and Europe.

Diabetes management has emerged as the second-largest segment, reaching 19.5 million connections worldwide in 2025. Growth is being supported by the expanding use of continuous glucose monitoring (CGM) and connected insulin delivery systems from companies including Abbott, Dexcom, Insulet, Tandem Diabetes Care and MiniMed.

Cardiac rhythm management represents another established application, with manufacturers such as Medtronic, Abbott, Boston Scientific and BIOTRONIK having incorporated connectivity into implantable devices for more than two decades.

Looking ahead, Berg Insight expects diabetes management, remote electrocardiogram (ECG) monitoring and medication compliance monitoring to be among the fastest-growing categories through 2030.

Connected Healthcare Is Moving Beyond Device Connectivity

One significant development highlighted by the research is the growing importance of software and service platforms within the mHealth ecosystem.

While connected medical devices provide the underlying patient measurements, platforms from companies such as Huma Therapeutics, Doccla, Teladoc Health, CareSimple and Current Health support the collection, analysis and management of patient information across remote care programmes.

This changes the requirements for healthcare IoT deployments. Reliable device connectivity remains essential, but delivering clinical value increasingly depends on the ability to consolidate information from different devices, present meaningful insights to medical professionals and integrate monitoring into existing care processes.

For medical device manufacturers and IoT solution providers, this creates an important distinction between selling connected hardware and participating in a complete remote patient monitoring ecosystem. Device interoperability, dependable data delivery and integration with healthcare software become important considerations as deployments expand across multiple medical conditions and care providers.

The trend also has implications for system integrators and connectivity providers. Medical monitoring applications must support different device types, patient environments and data collection requirements, making end-to-end service reliability an important operational consideration.

AI Adds Another Layer to Remote Patient Monitoring

Artificial intelligence is becoming increasingly relevant as healthcare organisations seek to extract actionable information from growing volumes of remotely collected patient data.

According to Berg Insight, AI and machine learning can help identify early indications of patient deterioration, support clinical decision-making and enable more proactive interventions outside traditional healthcare facilities.

However, the growing use of analytics also reinforces the importance of distinguishing between collecting more data and making that data clinically useful. Continuous monitoring may produce a richer picture of a patient’s condition, but its practical value depends on how effectively healthcare professionals can interpret and act on the information.

The broader direction of the market is therefore not simply towards a larger population of connected medical devices. It is towards integrated home monitoring systems combining medical hardware, connectivity, software and analytics as part of routine patient care.

For the IoT industry, Berg Insight’s forecast points to a market where long-term opportunities increasingly extend beyond device connections to the infrastructure and services required to deliver dependable, clinically relevant remote monitoring at scale.

The post Connected Home Medical Monitoring Devices to Reach 160 Million by 2030 appeared first on IoT Business News.